Which CEO pioneered the 'humanitarian pricing model' for essential medicines, setting prices based on a country's economic status rather than market demand?

The pharmaceutical and medical device industries have seen tremendous leadership changes and innovations in recent years. Some CEOs have revolutionized healthcare delivery, patient access, and treatment approaches through bold business decisions. This poll tests your knowledge of influential leadership in medical product innovation that changed how healthcare products reach patients worldwide.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Dr. Vasant Narasimhan (Novartis), who implemented tiered pricing across 80+ countries for heart failure and malaria medications
Emma Walmsley (GSK), who created the 'Global Access Initiative' with variable pricing based on GDP per capita
Albert Bourla (Pfizer), who developed the 'Fair Access Program' after the COVID-19 pandemic
Robert Ford (Abbott), who launched the 'Equitable Distribution Framework' for diabetes monitoring systems